Hawkins (NASDAQ:HWKN) Director Buys $193,935.00 in Stock

Hawkins, Inc. (NASDAQ:HWKN) Director James Faulconbridge purchased 1,500 shares of the firm’s stock in a transaction that occurred on Wednesday, February 4th. The shares were acquired at an average cost of $129.29 per share, with a total value of $193,935.00. Following the completion of the transaction, the director directly owned 50,907 shares of the company’s stock, valued at $6,581,766.03. The trade was a 3.04% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Hawkins Price Performance

Shares of NASDAQ:HWKN opened at $134.38 on Monday. The company has a market capitalization of $2.81 billion, a P/E ratio of 34.02, a price-to-earnings-growth ratio of 2.84 and a beta of 0.86. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.46 and a current ratio of 2.35. Hawkins, Inc. has a fifty-two week low of $98.30 and a fifty-two week high of $186.15. The company’s 50-day moving average is $144.54 and its 200 day moving average is $155.10.

Hawkins (NASDAQ:HWKN) last released its earnings results on Wednesday, January 28th. The specialty chemicals company reported $0.72 earnings per share for the quarter, missing analysts’ consensus estimates of $0.75 by ($0.03). The company had revenue of $244.08 million during the quarter, compared to analysts’ expectations of $252.51 million. Hawkins had a net margin of 7.75% and a return on equity of 16.85%. On average, equities research analysts forecast that Hawkins, Inc. will post 4 earnings per share for the current year.

Hawkins Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 27th. Investors of record on Friday, February 13th will be issued a $0.19 dividend. The ex-dividend date of this dividend is Friday, February 13th. This represents a $0.76 annualized dividend and a yield of 0.6%. Hawkins’s dividend payout ratio (DPR) is 19.24%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on HWKN shares. Weiss Ratings lowered shares of Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, January 12th. Zacks Research raised Hawkins from a “strong sell” rating to a “hold” rating in a report on Friday, January 2nd. Finally, BWS Financial reiterated a “buy” rating and issued a $200.00 target price on shares of Hawkins in a research report on Thursday, January 29th. Two equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $162.50.

Trending Headlines about Hawkins

Here are the key news stories impacting Hawkins this week:

• Positive Sentiment: Director James A. Faulconbridge increased his stake, purchasing 1,500 shares at an average $129.29 (total ~$193,935), bringing his holdings to ~50,907 shares (worth ~ $6.58M). Insider buying by a director is typically viewed as a confidence signal and likely helped lift the stock. Top Insider Just Made a Big Bet on This Under-the-Radar Company SEC Form 4
• Neutral Sentiment: Reported short interest shows 0 shares and a 0.0 days-to-cover ratio — this appears to be a reporting artifact or a very low short interest reading. Low/zero short interest reduces short-squeeze risk but offers limited directional insight. (Source: market data entry)
• Negative Sentiment: Sidoti (coverage) trimmed its FY2027 EPS estimate for Hawkins from $5.10 to $4.60 and published a cautious near-term view; the firm projects FY2028 at $5.10 and Q3 2028 at $1.01. Analyst downgrades can pressure the stock by lowering near-term expectations and investor sentiment. Sidoti Csr Has Pessimistic View of Hawkins FY2026 Earnings

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Capital World Investors raised its holdings in Hawkins by 618.8% during the third quarter. Capital World Investors now owns 355,619 shares of the specialty chemicals company’s stock valued at $64,979,000 after acquiring an additional 306,143 shares during the period. Invesco Ltd. grew its stake in shares of Hawkins by 44.4% in the 3rd quarter. Invesco Ltd. now owns 407,793 shares of the specialty chemicals company’s stock worth $74,512,000 after buying an additional 125,444 shares in the last quarter. Schroder Investment Management Group grew its position in Hawkins by 130.7% in the second quarter. Schroder Investment Management Group now owns 149,397 shares of the specialty chemicals company’s stock worth $21,229,000 after acquiring an additional 84,651 shares in the last quarter. Granite Investment Partners LLC purchased a new position in shares of Hawkins in the 3rd quarter worth approximately $11,610,000. Finally, Segall Bryant & Hamill LLC boosted its stake in Hawkins by 76.1% during the second quarter. Segall Bryant & Hamill LLC now owns 112,431 shares of the specialty chemicals company’s stock worth $15,976,000 after buying an additional 48,602 shares during the period. Hedge funds and other institutional investors own 69.71% of the company’s stock.

About Hawkins

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.